Pfizer's Lyme Disease Vaccine Shows 70% Success in Trial

After decades without a vaccine option, Pfizer's new Lyme disease vaccine showed over 70% effectiveness in preventing infection among 9,400 participants.

The breakthrough could protect the 476,000 Americans infected annually from a disease that often leads to chronic arthritis and heart problems.